Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

The North Carolina Department of Health and Human Services on Wednesday updated its weekly Respiratory Virus Summary Dashboard, which shows an increase in flu activity and flu-related deaths, bringing ...

The H1pdm09 subtype of the Influenza A virus continues to circulate in Armenia, along with other respiratory infections, ...

RALEIGH — The N.C. Department of Health and Human Services on Wednesday reported an increase in flu activity and flu-related deaths, bringing the total number of deaths this season to 117.

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...